医学
随机对照试验
阻塞性睡眠呼吸暂停
血压
麻醉
回廊的
持续气道正压
睡眠呼吸暂停
置信区间
平均差
气道管理
临床试验
气道正压
呼吸暂停
呼吸
气道
内科学
作者
Huijie Yi,Dong Xiaosong,Zhang Chi,Zhiyong Li,Wenjing Yang,Yuhua Zuo,Peijun Xue,Shuai Wu,Xu Li,Han Fang
标识
DOI:10.1093/ajrccm/aamag627
摘要
RATIONALE: Telemedicine improves access to obstructive sleep apnea (OSA) care, but whether telemedicine-based auto-adjusting positive airway pressure (APAP) management is noninferior to in-person care for the 3-month change in 24-hour mean blood pressure (BP) remains uncertain. OBJECTIVES: To determine whether comprehensive telemedicine-based APAP management is noninferior to standard in-person care in reducing 24-hour mean BP in patients with OSA. METHODS: In this prospective, randomized non-inferiority trial, 344 participants with suspected OSA were randomized 1:1 to telemedicine-based (TM) or in-person (IP) management for 3 months. The primary outcome was the between-group difference in change in 24-hour mean BP. The prespecified non-inferiority margin was 1.5 mmHg. Secondary outcomes included APAP adherence, patient-centered outcomes and metabolic parameters. MEASUREMENTS AND MAIN RESULTS: Of 344 randomized participants, 256 completed the 3-month follow-up (127 IP and 129 TM). The between-group difference (TM - IP) in the change in 24-hour mean BP was -0.59 mmHg (95% CI, -2.42 to 1.25) in the intention-to-treat analysis and -1.21 mmHg (95% CI, -3.24 to 0.81) in the completer analysis. Both upper confidence limits were below the prespecified 1.5-mmHg non-inferiority margin. No clear evidence of between-group differences was observed in APAP adherence, patient-reported outcomes, or metabolic measures. CONCLUSIONS: Telemedicine-based APAP management was noninferior to in-person management for the 3-month change in 24-hour mean BP, using a prespecified margin of 1.5 mmHg. These findings support telemedicine as a potential alternative delivery model for blood pressure management in patients with OSA.
科研通智能强力驱动
Strongly Powered by AbleSci AI